Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$AMLM !!! :)
Love from Jesus on a Monday!!!!!!!!!!! :)
Love from Jesus on a Monday!!!!!!!!!!! :)
Love from Jesus on a Monday!!!!!!!!!!! :)
Harry Lander Managing Partner
Dr. Lander has over 25 years of professional scientific, business and financial management experience related to biomedical research. Dr. Lander has had extensive experience in establishing the Sidra Medical and Research Center in Qatar as well as establishing Weill Cornell Medical College – Qatar. He has extensive relationships with large and small biotechnology / pharmaceutical companies and entities that can be leveraged for economic and scientific growth. Dr. Lander is currently President of RegenBioPharma, Inc. a publicly traded biotechnology company. Formerly he has served as Research Chief / Administration for Sidra Medical and Research Center (Doha, Qatar) and Assistant Provost for Weill Cornell Medical College (Cornell University). He has extensive experience running complex
organizations and establishing new ones
https://www.dyobiotechnologies.com/team/
$RGBP
why hasn't it been already????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
EOD Buy Vol. 588,977,288 Sell Vol. 5,301,000 ? Vol. 1,308,075
https://ih.advfn.com/stock-market/USOTC/gncc-capital-pk-GNCP/trades
$GNCP !!! :)
MORE!!! Love from Jesus!!!!!!! :)
MORE!!! Love from Jesus!!!!!!! :)
MORE!!! Love from Jesus!!!!!!! :)
$GNCP Buy Vol. 538,127,214 Sell Vol. 5,301,000 ? Vol. 1,208,075
https://ih.advfn.com/stock-market/USOTC/gncc-capital-pk-GNCP/trades
Buy Vol. 450,302,741 Sell Vol. 9,100,001 ? Vol. 686,509
https://ih.advfn.com/stock-market/USOTC/gncc-capital-pk-GNCP/trades
$NTRR !!! :)
$ADTM !!! :)
Love from Jesus!!!!!!! :)
Love from Jesus!!!!!!! :)
Love from Jesus!!!!!!! :)
Hi Squirrely!! :)
TWEET!!! Fastest growing bottling company :) $HIRU
$HIRU pic.twitter.com/n4LdNiBE0N
— HIRUCORP (@hirucorp) March 11, 2022
Nice!!! YEEHAW!!! :) $RGBP !!! :)
Hi! :)
$TLSS !!! :) :) :)
$ADTM !!!! :)
$RGBP !!! :) :) :)
$GNCP !!! :)
Maverik to Sell Alkaline88 Water Retailer has 370 stores across 12 states
https://www.cspdailynews.com/beverages/maverik-sell-alkaline88-water
CEFCO to Carry Alkaline88 1-Liters Water company continues expansion in c-stores
https://www.cspdailynews.com/beverages/cefco-carry-alkaline88-1-liters
Maybe they buy-out/merge $HIRU?? :)
Neutra's Revamped eCommerce Sites to Provide Powerful Platform for Upcoming Deity Wellness Product
Mon, March 7, 2022, 9:40 AM·3 min read
In this article:
NTRR
-11.11%
KATY, TX / ACCESSWIRE / March 7, 2022 / Neutra Corp. (OTC PINK:NTRR) is putting the final touches on its upgraded ecommerce platforms for subsidiaries VIVIS and Deity Wellness and expects to go live within a few weeks. The improved sites' first mission will be to support the launch of a new top-quality, high-value Deity product that will offer a robust, hemp-based alternative for the growing cannabinoid market.
"Our customers are going to really enjoy our new product offering," said Neutra CEO Sydney Jim. "We've always been a future-oriented company and the new product along with the upgraded ecommerce sites are all about reaching towards tomorrow. We see the future as producing quality hemp-based alternatives that consumers can afford in these increasingly troublesome economic times. And we view a significant online presence as necessary for future success. We'll be well-positioned for that success with these actions."
Neutra brands' market differentiators have traditionally been that they have always met the highest standards in quality backed by third-party lab testing to ensure consistency and potency. Thanks to manufacturing improvements, VIVIS and Deity Wellness can now also add value to their lists of what makes their products better than the competition's.
Neutra has also been busy revamping its ecommerce sites. The goal is to ensure each platform has the highest level of search engine optimization so that potential customers can find and use the platforms. Once on the site, specialized branding messages will tell VIVIS' and Deity Wellness' value proposition and explain what makes them the right choice for consumers looking for high quality at an affordable price. The upgraded sites are expected to pay off in higher sales and revenues as more and more consumers prefer the convenience of online shopping instead of visiting and brick and mortar store.
About Neutra Corp.
Neutra Corp. (OTC PINK:NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food, and drug, and environmental purification sectors are creating a new kind of world culture-one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate.
https://finance.yahoo.com/news/neutras-revamped-ecommerce-sites-powerful-164000501.html
$RGBP ! :)
Mods... OOPS for multiples posts... iHUB seems glitchy today..
Q: Why did the Referees pause the leper hockey game?
A: There was a face-off at center ice!
Q: Why did the Referees pause the leper hockey game?
A: There was a face-off at center ice!
Q: Why did the Referees pause the leper hockey game?
A: There was a face-off at center ice!
Q: Why did the Referees pause the leper hockey game?
A: There was a face-off at center ice!
$GCNP !!! :)
Oncology Pharma Reports on Progress with Ribera Solutions
March 02 2022 - 06:03AM
InvestorsHub NewsWire
Alert
Print
Share On Facebook
SAN FRANCISCO, CA -- March 2, 2022 -- InvestorsHub NewsWire -- Oncology Pharma Inc. (OTC PINK: ONPH) - Oncology Pharma, Inc. ("The Company") is pleased to announce progress with its investment with Ribera Solutions' Connect2Med. Ribera has segregated the business entity into a separate business unit and made it an independent entity as a Delaware Corporation under the name of Connect2Trials, Inc. Oncology Pharma's investment has been transferred to the new business and it has committed to further finance the commercial development for a significant interest in the business.
Connect2Trials, Inc. is currently developing a prototype to present and demonstrate capabilities to companies including some of the largest pharma and biotech companies in the industry. The prototype target date is scheduled for late March of 2022 subject to the availability of adequate financing. Connect2Trials is in current discussions with some of the top CRO's (Clinical Research Organizations), Advocacy Groups, and Pharma Companies for potential partnerships for pilot deployment of its MVP (Minimum Viable Product) release scheduled for 2nd quarter of this year.
For Pharmaceutical companies, CROs and sites running clinical trials, Connect2Trials offers a highly engaging patient retention platform that keeps patients motivated to complete the trial, which is currently a challenge for many trials. Connect2Trials does this through community and peer to peer interactions and incentives.
Oncology Pharma, Inc, through its investment and continuation of financing of Connect2Trials is poised to become a significant player in the trials and patient engagement space in order to increase the results of clinical trials utilizing technology and patient engagement formulas to improve the retention rate, value proposition and eventual better clinical trials in the industry.
ABOUT ONCOLOGY PHARMA, INC.
ONCOLOGY PHARMA, INC. (OTCPK: ONPH) (the "Company") is currently engaging in research and development of therapeutics for oncology and prides itself for having a world-class Advisory Board that keeps the Company in the forefront of developing technologies in cancer research, biotechnology, and healthcare.
ABOUT Ribera Solutions, LLC (Connect2Trials, inc.) (www.riberasolutions.com)
Ribera Solutions (CA, USA) has developed Web based Connect2Med platform, which has been recently assigned to Connect2Trials, Inc., with iOS and Android mobile Apps. Ribera's mission is to provide solutions for solving challenging problems timely through simple, practical and economical approaches.
https://ih.advfn.com/stock-market/USOTC/oncology-pharma-pk-ONPH/stock-news/87436366/oncology-pharma-reports-on-progress-with-ribera-so
Amen! :)
chill.... :)